World's Best Scientists 2026 revealed!
Ahmad A. Tarhini

Ahmad A. Tarhini

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
16525
World Ranking
10093
National Ranking
4415

Ahmad A. Tarhini publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Ahmad A. Tarhini sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 663 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Ahmad A. Tarhini D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ahmad A. Tarhini sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 63 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Ahmad A. Tarhini is affiliated with the Cleveland Clinic in the United States and has extensive research experience in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work primarily focuses on oncology and related biomedical disciplines, with a considerable output in subfields such as Oncology, Molecular Biology, Immunology, Cancer Research, and Pulmonary and Respiratory Medicine.

The scientist's research topics encompass a diverse range of cancer-related themes, including:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Cutaneous Melanoma Detection and Management
  • Immunotherapy and Immune Responses
  • Melanoma and MAPK Pathways
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies

Ahmad A. Tarhini has contributed to multiple frequent publication venues, such as:

  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Annals of Oncology
  • Journal for ImmunoTherapy of Cancer

Among the co-authors who have frequently collaborated with Tarhini are:

  • Vernon K. Sondak
  • Nikhil I. Khushalani
  • Michelle L. Churchman
  • John M. Kirkwood
  • Aik Choon Tan

Significant papers authored or co-authored by Ahmad A. Tarhini include:

  • Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC), 2021, Nature Medicine
  • Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134, 2022, Journal of Clinical Oncology
  • Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204), 2021, Neuro-Oncology
  • Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial, 2022, The Lancet
  • DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial-ECOG-ACRIN EA6134, 2021, Journal of Clinical Oncology

Best Publications

  • Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

    Hussein A. Tawbi;Peter A. Forsyth;Alain Algazi;Omid Hamid

  • Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination

    Celine Boutros;Ahmad Tarhini;Emilie Routier;Olivier Lambotte

  • Prognostic significance of autoimmunity during treatment of melanoma with interferon

    Michal T. Krauze;Ahmad Tarhini;Helen Gogas;John M. Kirkwood

  • Immunotherapy of Cancer in 2012

    John M. Kirkwood;Lisa H. Butterfield;Ahmad A. Tarhini;Hassane Zarour

  • Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

    Ahmad A. Tarhini;Howard D Edington;Lisa H. Butterfield;Yan Lin

  • Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

    Ahmad A. Tarhini;Haris Zahoor;Yan Lin;Usha Malhotra

  • Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

    Alexander M. Menzies;Alexander M. Menzies;Rodabe N. Amaria;Elisa A. Rozeman;Alexander C. Huang

  • Next Generation of Immunotherapy for Melanoma

    John M. Kirkwood;Ahmad A. Tarhini;Monica C. Panelli;Stergios J. Moschos

  • Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management.

    Ahmad Tarhini

  • Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy

    John M. Kirkwood;Catherine Bender;Sanjiv Agarwala;Ahmad Tarhini

  • Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

    Kenneth A. Foon;Michael Boyiadzis;Stephanie R. Land;Stanley Marks

  • PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines

    Julien Fourcade;Zhaojun Sun;Ornella Pagliano;Joe Marc Chauvin

  • Future perspectives in melanoma research

    Paolo A. Ascierto;Sanjiv Agarwala;Gerardo Botti;Alessandra Cesano

  • The society for immunotherapy of cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma

    Howard L. Kaufman;John M. Kirkwood;F. Stephen Hodi;Sanjiv Agarwala

  • Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12

    Theofanis Floros;Ahmad A. Tarhini

  • Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.

    L. Khoja;L. Khoja;E. G. Atenafu;S. Suciu;S. Leyvraz

  • Releasing the Brake on the Immune System: Ipilimumab in Melanoma and Other Tumors

    Ahmad Tarhini;Ernest Lo;David R. Minor

  • Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.

    Donald N. Liew;Hideyuki Kano;Douglas Kondziolka;David Mathieu

  • Cutaneous melanoma: available therapy for metastatic disease.

    Ahmad A. Tarhini;Sanjiv S. Agarwala

  • Safety and efficacy of combination immunotherapy with interferon Alfa-2b and tremelimumab in patients with stage IV melanoma

    Ahmad A. Tarhini;John Cherian;Stergios J. Moschos;Hussein A. Tawbi

Frequent Co-Authors

John M. Kirkwood
John M. Kirkwood University of Pittsburgh
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco
Michael B. Atkins
Michael B. Atkins Georgetown University
Vernon K. Sondak
Vernon K. Sondak University of South Florida
David F. McDermott
David F. McDermott Beth Israel Deaconess Medical Center
Kim Margolin
Kim Margolin City Of Hope National Medical Center
William E. Gooding
William E. Gooding University of Pittsburgh
F. Stephen Hodi
F. Stephen Hodi Harvard University
Omid Hamid
Omid Hamid Cedars-Sinai Medical Center
Antoni Ribas
Antoni Ribas University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about Biology and Biochemistry, a wide range of online degree paths and professional certifications can broaden your career options. For those interested in the healthcare side, psychiatric mental health nursing is in high demand. Completing the shortest pmhnp program can quickly lead to advanced nursing positions and expanded patient care opportunities.

Nutrition is also a fast-growing field in life sciences. Choosing a fastest nutrition degree online lets you quickly enter roles focused on public health, wellness, or clinical nutrition without lengthy campus commitments.

For those looking to combine science knowledge with leadership skills, a graduate degree in healthcare management may be a smart move. Considering the healthcare mba cost can help you find quality programs that fit your budget and career goals.

Certification also opens new doors. Understanding ccs certification options puts you on a path toward medical coding, data analysis, and informatics roles—key areas in today’s healthcare landscape.

Best Scientists Citing Ahmad A. Tarhini

Trending Scientists

Recently Published Articles